Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

The role of near-infrared spectroscopy in the detection of vulnerable atherosclerotic plaques.

Horvath M, Hajek P, Stechovsky C, Honek J, Spacek M, Veselka J.

Arch Med Sci. 2016 Dec 1;12(6):1308-1316. Epub 2016 Oct 24.

2.

Stabilization of high-risk plaques.

Takata K, Imaizumi S, Zhang B, Miura S, Saku K.

Cardiovasc Diagn Ther. 2016 Aug;6(4):304-21. doi: 10.21037/cdt.2015.10.03. Review.

3.

Intracoronary Imaging in the Detection of Vulnerable Plaques.

Batty JA, Subba S, Luke P, Gigi LW, Sinclair H, Kunadian V.

Curr Cardiol Rep. 2016 Mar;18(3):28. doi: 10.1007/s11886-016-0705-1. Review.

4.

Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies.

Banach M, Serban C, Sahebkar A, Mikhailidis DP, Ursoniu S, Ray KK, Rysz J, Toth PP, Muntner P, Mosteoru S, García-García HM, Hovingh GK, Kastelein JJ, Serruys PW; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group..

BMC Med. 2015 Sep 18;13:229. doi: 10.1186/s12916-015-0459-4. Review.

5.

Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.

Serra N, Rosales R, Masana L, Vallvé JC.

PLoS One. 2015 Jul 24;10(7):e0133875. doi: 10.1371/journal.pone.0133875. eCollection 2015 Jul 24.

6.

Imaging plaques to predict and better manage patients with acute coronary events.

Garcia-Garcia HM, Jang IK, Serruys PW, Kovacic JC, Narula J, Fayad ZA.

Circ Res. 2014 Jun 6;114(12):1904-17. doi: 10.1161/CIRCRESAHA.114.302745. Review.

7.

Volumetric quantification of fibrous caps using intravascular optical coherence tomography.

Wang Z, Chamie D, Bezerra HG, Yamamoto H, Kanovsky J, Wilson DL, Costa MA, Rollins AM.

Biomed Opt Express. 2012 Jun 1;3(6):1413-26. doi: 10.1364/BOE.3.001413. Epub 2012 May 16.

8.

Optical Coherence Tomography and Fibrous Cap Characterization.

Chamié D, Wang Z, Bezerra H, Rollins AM, Costa MA.

Curr Cardiovasc Imaging Rep. 2011 Aug;4(4):276-283. Epub 2011 May 12.

9.

Optical coherence tomography imaging in acute coronary syndromes.

Kubo T, Ino Y, Tanimoto T, Kitabata H, Tanaka A, Akasaka T.

Cardiol Res Pract. 2011;2011:312978. doi: 10.4061/2011/312978. Epub 2011 Sep 21.

10.

Multimodality cardiovascular molecular imaging technology.

O'Donnell M, McVeigh ER, Strauss HW, Tanaka A, Bouma BE, Tearney GJ, Guttman MA, Garcia EV.

J Nucl Med. 2010 May 1;51 Suppl 1:38S-50S. doi: 10.2967/jnumed.109.068155. Review.

11.

Intracoronary optical coherence tomography: a comprehensive review clinical and research applications.

Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI.

JACC Cardiovasc Interv. 2009 Nov;2(11):1035-46. doi: 10.1016/j.jcin.2009.06.019. Review.

12.

A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium.

Heinonen T, Waters DD, Libby P, Tardif JC.

Can J Cardiol. 2009 Sep;25(9):527-32. Review. No abstract available.

13.

Applications of optical coherence tomography in cardiovascular medicine, Part 2.

Villard JW, Paranjape AS, Victor DA, Feldman MD.

J Nucl Cardiol. 2009 Jul-Aug;16(4):620-39. doi: 10.1007/s12350-009-9100-2. Epub 2009 May 29. Review. No abstract available.

Supplemental Content

Support Center